Geode Capital Management’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2K Hold
1,348
﹤0.01% 4482
2025
Q4
$24.7K Hold
1,348
﹤0.01% 4358
2025
Q3
$41.3K Hold
1,348
﹤0.01% 4331
2025
Q2
$40.3K Hold
1,348
﹤0.01% 4257
2025
Q1
$48.1K Hold
1,348
﹤0.01% 4210
2024
Q4
$44.5K Buy
1,348
+496
+58% +$11.4K ﹤0.01% 4262
2024
Q3
$15.6K Hold
852
﹤0.01% 4424
2024
Q2
$18.9K Hold
852
﹤0.01% 4463
2024
Q1
$30.7K Buy
+852
New +$33.3K ﹤0.01% 4409

Other funds holding ICCM

Geode Capital Management's ICCM Position: Q1 2026 in Review

Geode Capital Management held its IceCure Medical (ICCM) position steady in Q1 2026 at 1,348 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4482.

Geode Capital Management first reported a position in ICCM in Q1 2024 and has held it in 9 quarters since. The position peaked at $48.1K in Q1 2025. 17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

  • Geode Capital Management held 1,348 shares of IceCure Medical worth $12.2K as of Q1 2026.
  • Geode Capital Management left its IceCure Medical share count unchanged in Q1 2026.
  • IceCure Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4482 holding.
  • Geode Capital Management first reported a position in IceCure Medical in Q1 2024 and has held it in 9 quarters since.
  • Geode Capital Management's IceCure Medical position peaked at $48.1K in Q1 2025.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.